ARCUS BIOSCIENCES INC
NYSE: RCUS (Arcus Biosciences, Inc.)
Kemas kini terakhir: 4 jam lalu15.50
0.04 (0.26%)
| Penutupan Terdahulu | 15.46 |
| Buka | 15.11 |
| Jumlah Dagangan | 2,023,196 |
| Purata Dagangan (3B) | 763,356 |
| Modal Pasaran | 1,418,429,824 |
| Harga / Jualan (P/S) | 4.96 |
| Harga / Buku (P/B) | 2.46 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 19 Feb 2025 - 24 Feb 2025 |
| Margin Keuntungan | -102.66% |
| Margin Operasi (TTM) | -218.75% |
| EPS Cair (TTM) | -3.19 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 50.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 13.98% |
| Nisbah Semasa (MRQ) | 5.24 |
| Aliran Tunai Operasi (OCF TTM) | -158.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -53.50 M |
| Pulangan Atas Aset (ROA TTM) | -15.25% |
| Pulangan Atas Ekuiti (ROE TTM) | -49.77% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Arcus Biosciences, Inc. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | -2.5 |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Purata | 0.90 |
|
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 40.60% |
| % Dimiliki oleh Institusi | 60.05% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Invus Financial Advisors, Llc | 30 Jun 2024 | 1,612,077 |
| Boxer Capital, Llc | 30 Sep 2024 | 1,602,200 |
| Parkman Healthcare Partners Llc | 30 Sep 2024 | 1,025,754 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 30.00 (Wedbush, 93.55%) | Beli |
| Median | 29.00 (87.10%) | |
| Rendah | 20.00 (HC Wainwright & Co., 29.03%) | Pegang |
| Purata | 27.00 (74.19%) | |
| Jumlah | 3 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 16.21 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 06 Nov 2024 | 20.00 (29.03%) | Pegang | 15.73 |
| 24 Oct 2024 | 20.00 (29.03%) | Pegang | 17.83 | |
| Barclays | 25 Oct 2024 | 29.00 (87.10%) | Beli | 16.32 |
| Wells Fargo | 08 Oct 2024 | 29.00 (87.10%) | Beli | 17.47 |
| Wedbush | 03 Oct 2024 | 30.00 (93.55%) | Beli | 15.31 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| AZOY ALEXANDER | - | 15.77 | -5,976 | -94,230 |
| GOELTZ II ROBERT C. | - | 16.08 | -10,099 | -162,392 |
| JAEN JUAN C. | - | 16.08 | -17,286 | -277,959 |
| JARRETT JENNIFER | - | 16.08 | -27,501 | -442,216 |
| NUYTEN DIMITRY SA | - | 16.08 | -7,856 | -126,324 |
| ROSEN TERRY J | - | 16.08 | -37,882 | -609,143 |
| TANG CAROLYN C. | - | 16.08 | -11,339 | -182,331 |
| Jumlah Keseluruhan Kuantiti Bersih | -117,939 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -1,894,595 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 16.00 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| AZOY ALEXANDER | Pegawai | 19 Dec 2024 | Jual automatik (-) | 3,007 | 15.46 | 46,488 |
| JAEN JUAN C. | Pegawai | 15 Dec 2024 | Dibuang (-) | 17,286 | 16.08 | 277,959 |
| AZOY ALEXANDER | Pegawai | 15 Dec 2024 | Dibuang (-) | 2,969 | 16.08 | 47,742 |
| GOELTZ II ROBERT C. | Pegawai | 15 Dec 2024 | Dibuang (-) | 10,099 | 16.08 | 162,392 |
| NUYTEN DIMITRY SA | Pegawai | 15 Dec 2024 | Dibuang (-) | 7,856 | 16.08 | 126,324 |
| ROSEN TERRY J | Pegawai | 15 Dec 2024 | Dibuang (-) | 37,882 | 16.08 | 609,143 |
| TANG CAROLYN C. | Pegawai | 15 Dec 2024 | Dibuang (-) | 11,339 | 16.08 | 182,331 |
| JARRETT JENNIFER | Pegawai | 15 Dec 2024 | Dibuang (-) | 27,501 | 16.08 | 442,216 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |